Patents for C12R 1 - Micro-organisms (92,025)
09/1994
09/14/1994EP0614975A1 Glycoprotein hormone receptor molecules
09/14/1994EP0614973A1 Polypeptide useful in diagnosis of coccidia infection and recombinant-DNA methods for manufacturing same
09/14/1994EP0614972A2 N-Acetyl-D-glucosamine deacetylase and a process for preparing the same
09/14/1994EP0614969A2 Use of Herpes saimiri transformed lymphocytes in a process of multiplication of immune deficiency inducing virus of the HIV type
09/14/1994EP0614531A1 Process for detecting p53-specific antibodies
09/14/1994EP0614490A1 Production of proteins using 7b2 protein
09/14/1994EP0614489A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR
09/14/1994EP0614488A1 Recombinant vaccine against lyme disease
09/14/1994EP0614465A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG
09/14/1994EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
09/14/1994EP0575528A4 Response element compositions and assays employing same
09/14/1994EP0542761B1 Eliminating internal initiation of soluble cd4 gene
09/14/1994EP0511221B1 Process for enriching or cleaning hirudin
09/14/1994EP0485525B1 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin
09/14/1994EP0339040B1 Swine dysentery vaccine
09/14/1994EP0162078B1 Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein
09/13/1994US5346822 Alkaline proteases from Bacillus pumilus
09/13/1994US5346821 Thermostable protease from Staphylothermus
09/13/1994US5346820 Detergents
09/13/1994US5346819 Glycerol dehydrogenase, process for its production and its use
09/13/1994US5346816 Enzymatic process for the enantioselective preparation of optically active cyanohydrins
09/13/1994CA2118843A1 Use of lymphocytes transformed with herpesvirus saimiri on a process for replicating viruses of the hiv type which cause immune deficiency
09/10/1994CA2118558A1 Soluble human fc-gamma iii receptors, process for the preparation thereof, pharmaceutical compositions containing same, utilization thereof as medicaments, and diagnostic application thereof
09/07/1994EP0613951A2 Novel polysaccharides, process for producing polysaccharides, uses of polysaccharides and Azotobacter beijerinckii TNM1
09/07/1994EP0613949A2 Gene encoding chondroitinase ABC and uses therefor
09/07/1994EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules
09/07/1994EP0613499A1 Human il-4 mutant proteins
09/07/1994EP0613498A1 Receptor derivates with binding sites for human rhinoviruses
09/07/1994EP0613497A1 Lymphoid cd30-antigen.
09/07/1994EP0613496A1 Collagen-like polypeptides
09/07/1994EP0613479A1 Marcfortine/paraherquamide derivatives useful as antiparasitic agents
09/07/1994EP0479820B1 A bacterial preparation for use in poultry
09/07/1994EP0462210B1 Vaccines for nontypable haemophilus influenzae
09/06/1994US5344994 Fermenting eugenol with fungi; carbonylation
09/06/1994US5344913 Biodegradable; high strength detergent
09/06/1994US5344778 Process for enzymatic cleavage of C-S bonds and process for reducing the sulfur content of sulfur-containing organic carbonaceous material
09/06/1994US5344777 Structural gene of membrane-bound alcohol dehydrogenase complex, plasmid containing the same and transformed acetic acid bacteria
09/06/1994US5344773 Human uterine tissue plasminogen activator produced by recombinant DNA
09/06/1994US5344771 Plant thiosterases
09/06/1994US5344769 Aerobic fermentation of Pseudomonas in nutrient medium of aliphatic hydrocarbon; lactonization, esterification
09/06/1994US5344647 Strain of microorganism having antimicrobial activity
09/03/1994CA2116710A1 Method for production of lactic acid and lactic esters
09/01/1994WO1994019528A1 A process for providing localized variation in the colour density of fabrics
09/01/1994WO1994019483A1 Process for producing canthaxanthin
09/01/1994WO1994019482A1 Heterologous antigens in live cell vaccine strains
09/01/1994WO1994019475A2 Yeast agglutination genes and yeast containing them
09/01/1994WO1994019472A2 Bi-functional expression system
09/01/1994WO1994019471A1 Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria
09/01/1994WO1994019470A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases
09/01/1994WO1994019466A2 A novel family of anti-carcinoembryonic antigen chimeric antibodies
09/01/1994WO1994019464A2 Human dna sequence encoding a kidney atp-dependent potassium channel
09/01/1994WO1994019462A1 Harp family growth factors, preparation methods therefor and uses thereof
09/01/1994WO1994019457A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
09/01/1994WO1994019454A2 An amylolytic enzyme
09/01/1994WO1994019016A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors
09/01/1994WO1994016069A3 Ras associated gap proteins
09/01/1994WO1994012638A3 Interleukin-3 (il-3) multiple mutation polypeptides
09/01/1994WO1993012756A3 Transfection of lung via aerosolized transgene delivery
09/01/1994CA2156850A1 Harp family growing factors, preparation methods and uses thereof
09/01/1994CA2156302A1 An amylolytic enzyme
09/01/1994CA2156260A1 Bi-functional expression system
09/01/1994CA2156191A1 Heterologous antigens in live cell vaccine strains
09/01/1994CA2155934A1 A novel family of anti-carcinoembryonic antigen chimeric antibodies
09/01/1994CA2134354A1 Yeast agglutination genes and yeast containing them
08/1994
08/31/1994EP0612849A2 Cloning and identification of a two component signal transducing regulatory system from bacteroides fragilis
08/31/1994EP0612847A2 Anti microbial proteins
08/31/1994EP0612846A1 G-CSF analog compositions and methods
08/31/1994EP0612742A1 A physiologically active bisindole-pyrrole derivative
08/31/1994EP0612527A2 Use of rhamnan, rhamnose or rhamnose oligomers for the treatment of gastric ulcer
08/31/1994EP0612351A1 Microbial production of cis-dihydrodiol and phenol derivatives of benzocyclobutene
08/31/1994EP0612350A1 Ubiquitin-specific proteases
08/31/1994EP0612348A1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
08/31/1994EP0612325A1 Recombinant core-streptavidin
08/31/1994EP0612218A1 NOVEL COLEOPTERAN-ACTIVE $i(BACILLUS THURINGIENSIS) ISOLATES AND GENES ENCODING COLEOPTERAN-ACTIVE TOXINS
08/31/1994EP0536192B1 New promoter region
08/31/1994EP0506833B1 Method of preparation of hirudin
08/31/1994EP0499622B1 Site-specific modification of the candida tropicalis genome
08/31/1994EP0487541B1 Dna encoding a lipase and a lipase modulator
08/31/1994EP0259475B1 Recombinant human endothelial cell growth factor
08/31/1994EP0228449B1 Fibroblast growth factor
08/31/1994CN1091472A Stereoselective reduction of ketones
08/31/1994CN1091471A Detection of DNA sequences and the novel DNA sequence encoding a novel neuropolypeptide and a neuropolypeptide encoded thereby
08/31/1994CN1091470A Unreductases produced of saccharide preparation and application of same
08/30/1994US5342930 Genetic engineering
08/30/1994US5342831 Wound healing, bed sores
08/30/1994US5342830 Antithrombosis agents
08/30/1994US5342778 Microorganism belonging to the genus flavobacterium designated ferm BP-4010
08/30/1994US5342775 Purified DNA that codes for plasminogen activator with sequence similar to human pruoro kinase; cerebral thrombosis and myocardial infarction
08/30/1994US5342774 Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
08/30/1994US5342757 Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
08/30/1994US5342615 Method for treating arthritis or inflammation with Il-1α or derivatives thereof
08/30/1994US5342547 Agents for controlling underwater fouling organisms
08/27/1994CA2116516A1 Antiulcer agent and process for preparing the same
08/27/1994CA2116422A1 Cloning and identification of a two component signal transducing regulatory system from bacteroides fragilis
08/25/1994DE4337197C1 Process for the selective preparation of hybridoma cell lines which produce monoclonal antibodies with high cytotoxicity against human CD16 antigen, and the preparation of bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody for therapy of human tumours
08/25/1994CA2116202A1 Hyper-sensitivity related gene
08/25/1994CA2116201A1 Anti-microbial proteins
08/24/1994EP0611822A2 More complex type retroviruses having mixed type LTR, and uses thereof
08/24/1994EP0611729A1 Method for biodegrading trichloroethylene and method for biodegrading chlorinated organic compound by microorganisms
08/24/1994EP0611397A1 Feline leukemia virus vaccines